15% of Parkinson’s cases linked to genetic factors, study says
Centogene has announced data from its Rostock International Parkinson’s Disease (ROPAD) Study revealing the genetic factors and prevalence of Parkinson’s disease (PD).
The findings from the study indicate that approximately 15% of PD-related cases are tied to genetic variants, with the majority being linked to LRRK2 and GBA1. The data was published in Brain in a paper titled, ‘Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study’.
“Over the past five years, Centogene and our more than 100 study sites around the world have worked together to diagnose Parkinson’s patients and accelerate treatment options,” said Professor Peter Bauer, Chief Medical and Genomic Officer at Centogene. “Our collaborative work clearly shows how significant of a role genetics plays in Parkinson’s disease and underscores the need to integrate genetic testing in routine care of these patients. This will not only enable access to potentially available treatments, but will de-risk and accelerate the development of gene-specific therapies – driving the future of Parkinson’s disease patient care.”
The research investigated variants in 50 genes with either an established relevance for PD or possible phenotypic overlap from over 12,500 patients from 16 countries who have been enrolled in Centogene’s ROPAD Study. In more than 1,800 participants, a PD-relevant genetic test (PDGT) provided a positive result. This included variants linked to the LRRK2 and GBA1 genes, as well as PRKN, SNCA, and PINK1, or a combination of genetic findings in multiple genes.
In the emerging era of gene-targeted PD clinical trials, Centogene’s findings show that approximately 15% of patients harbour potentially actionable genetic variants offers an important prospect to affected individuals and their families and underlines the need for genetic testing in PD patients. By capturing such genetic data, this also allows for differential genetic counselling across the spectrum of different ages at onset and family histories.
Megan Thomas, Multimedia Editor, DDW
